|
In the quarter April – Jun 2008, Claris successfully achieved a milestone record of its first fifty product registrations across Europe and other regulated markets. |
|
| This achievement provides a significant boost to Claris’ strategy for the Regulated comprising US, EU, Australia and New Zealand. | |
| The US & EU markets alone account for over 60% of the global pharmaceutical market. - August 2008 | |
|
